Ridge Augmentation Without Primary Closure
Launched by UNIVERSITY OF LOUISVILLE · Jul 16, 2013
Trial Information
Current as of May 19, 2025
Completed
Keywords
ClinConnect Summary
A maximum of 30 patients will be selected that meet the following criteria:
Inclusion Criteria
1. At least a one tooth area with a ridge defect, treatment planned to receive a dental implant. The site must be bordered by at least one tooth.
2. Healthy person that is at least 18 years old.
3. Patient understands and signs an informed consent approved by the University of Louisville Human Studies Committee.
Exclusion Criteria
1. Patients with debilitating systemic diseases, diseases that affect the periodontium, or psychological problems that would interfere with treatment.
2. Previous he...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. At least a one tooth area with a ridge defect, treatment planned to receive a dental implant. The site must be bordered by at least one tooth.
- • 2. Healthy person that is at least 18 years old.
- • 3. Patient understands and signs an informed consent approved by the University of Louisville Human Studies Committee.
- Exclusion Criteria:
- • 1. Patients with debilitating systemic diseases, diseases that affect the periodontium, or psychological problems that would interfere with treatment.
- • 2. Previous head and neck radiation or chemotherapy within the previous 12 months.
- • 3. Patients with known allergy to any of the materials that will be used in the study.
- • 4. Smokers.
- • 5. Patients who need prophylactic antibiotics prior to dental procedures.
- • 6. Patients on long-term steroid therapy or oral bisphosphonates \> 3 years or any IV biosphosphonates.
- • 7. Patients who are pregnant.
About University Of Louisville
The University of Louisville is a distinguished academic institution known for its commitment to advancing medical research and clinical innovation. As a clinical trial sponsor, the university leverages its extensive resources and expertise to conduct pioneering studies that aim to improve patient outcomes and enhance healthcare practices. With a focus on interdisciplinary collaboration and community engagement, the University of Louisville fosters an environment conducive to groundbreaking research across various medical fields, ensuring adherence to the highest ethical standards and regulatory compliance. Through its clinical trials, the university seeks to translate scientific discoveries into tangible benefits for patients and the broader community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Louisville, Kentucky, United States
Patients applied
Trial Officials
Henry Greenwell, DMD
Principal Investigator
University of Louisville
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials